The caveolin triad: Caveolae biogenesis, cholesterol trafficking, and signal transduction

Cytokine and Growth Factor Reviews

Volumn 12, Issue 1, 2001, Pages 41-51

  Schlegel, Amnon ^b   Lisanti, Michael P ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Cancer; Caveolae; Caveolin; Muscular dystrophy; Signal transduction

Indexed keywords

CAVEOLIN; CAVEOLIN 1; CAVEOLIN 3; CAVEOLIN-1; CAVEOLIN-3; CHOLESTEROL; COAT PROTEIN; MEMBRANE LIPID; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; CANCER; CAVEOLAE; CELL MEMBRANE; CHOLESTEROL TRANSPORT; CYTOPLASM; HUMAN; MEMBRANE VESICLE; MOLECULAR GENETICS; MUSCULAR DYSTROPHY; PHOSPHORYLATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; CAVEOLAE; CAVEOLIN 1; CAVEOLIN 3; CAVEOLINS; CHOLESTEROL; HUMANS; MOLECULAR SEQUENCE DATA; MUSCULAR DYSTROPHIES; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0035069676     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(00)00022-8     Document Type: Short Survey

References (98)

1. The fine structure of the gall bladder epithelium of the mouse
2. Fine structure of blood capillaries
3. Caveolae: Static inpocketings of the plasma membrane, dynamic vesicles or plain artifact?
4. Potocytosis: Sequestration and transport of small molecules by caveolae
5. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus
6. Caveolin, a protein component of caveolae membrane coats
7. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles
8. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin
9. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis
10. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes
11. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
12. A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface
13. VIP21/caveolin is a cholesterol-binding protein
14. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes
15. Identification of caveolin-1 as a fatty acid binding protein
16. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles
17. Plasma membrane caveolae mediate the efflux of cellular free cholesterol
18. Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae
19. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane
20. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking
21. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae
22. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae
23. Intracellular cholesterol transport in synchronized human skin fibroblasts
24. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae
25. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton
26. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane
27. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells
28. Purification and characterization of smooth muscle cell caveolae
29. A detergent-free method for purifying caveolae membrane from tissue culture cells
30. Separation of caveolae from associated microdomains of GPI-anchored proteins
31. Caveolins, liquid-ordered domains, and signal transduction
32. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts
33. The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles
34. Caveolae and sorting in the trans-Golgi network of epithelial cells
35. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae
36. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro
37. Oligomeric structure of caveolin: Implications for caveolae membrane organization
38. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo
39. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro
40. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo
41. Molecular characterization of caveolin association with the Golgi complex: Identification of a cis-Golgi targeting domain in the caveolin molecule
42. Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the Scaffolding Region of Caveolin and the Effector Region of MARCKS
43. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle
44. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae
45. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homo-typic caveolin-caveolin interactions
46. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation
47. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps
48. Influence of the HDL receptor SR-BI on atherosclerosis
49. Sterol carrier protein-2 alters HDL-mediated cholesterol efflux
50. Caveolae, caveolin and caveolin-rich membrane domains: A signalling hypothesis
51. Caveolin is present in intestinal cells: Role in cholesterol trafficking?
52. Functions of lipid rafts in biological membranes
53. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease
54. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin
55. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains
56. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the autoactivation of Src tyrosine kinases
57. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins
58. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
59. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer
60. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain
61. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth
62. Signal transduction of a G protein-coupled receptor in caveolae: Colocalization of endothelin and its receptor with caveolin
63. Targeting of a G alpha subunit (Gil alpha) and c-Src tyrosine kinase to caveolae membranes: Clarifying the role of N-myristoylation
64. Heterologous desensitization mediated by G protein-specific binding to caveolin
65. Inhibition of adenylyl cyclase by caveolin peptides
66. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A
67. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveotin binding domain in vivo
68. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy
69. Reconstitution of an endothelial nitric oxide synthase, hsp90 and caveolin-1 complex in vitro: Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1
70. Integrin signaling
71. Role of urokinase receptor and caveolin in regulation of integrin signaling
72. Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking
73. Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment
74. Signal transduction through priori protein
75. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain
76. The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo
77. Constitutive and growth factor regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src/Cav-1/Grb7 signaling cassette
78. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans
79. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK)
80. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
81. Reduction of caveolin and caveolae in oncogenically transformed cells
82. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
83. Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy
84. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family
85. Caveolin-1 and -2 in the exocytic pathway of MDCK cells
86. Caveolin-2 localizes to the Golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1
87. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex
88. M-caveolin, a muscle-specific caveolin-related protein
89. Affinity-purification and characterization of caveolins from the brain: Differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types
90. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins
91. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan: Identification of a central WW-like domain within caveolin family members
92. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
93. Caveolin-3 in muscular dystrophy
94. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia
95. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy
96. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the Golgi complex
97. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3
98. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype